Xbrane Biopharma Swells In Oncology With Keytruda And Darzalex Projects

With Opdivo Biosimilar, Three Products ‘Could Be Launched In 2028-2029’

 
• By Dean Rudge
  
Pair of aces with poker chips
Xbrane has announced a pair of new projects • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products